XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials SUZHOU, China, April 15, 2025 /PRNewswire/ — In January 2025 (U.S. time),… CISION PRNewswireApril 15, 2025
Press ReleaseCIRQUE DU SOLEIL INTRODUCES NEW INTERACTIVE DIGITAL EXPERIENCE, OFFERING BACKSTAGE ACCESS TO FANS Experience the world of KURIOS – Cabinet of Curiosities like never before… CISION PRNewswireApril 15, 2025
Press ReleaseReolink Earth Day 2025: Partnering with NGOs to Drive Global Conservation LOS ANGELES, April 15, 2025 /PRNewswire/ — It starts with a moment… CISION PRNewswireApril 15, 2025
Press ReleaseSECuRE trial update: First patient treated in the Phase II Cohort Expansion HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion… CISION PRNewswireApril 15, 2025
Thales to Offer Prime Factors' Bank Card Security System Prime Factors and Thales Extend Collaboration to Help Customers Build More Secure… CISION PRNewswireApril 15, 2025
Press ReleaseMarimekko and Blue Bottle Coffee Celebrate Finnish Coffee Culture and the Joy of Everyday Rituals Limited-edition collaboration launches in North America and Asia on April 25 OAKLAND,… CISION PRNewswireApril 15, 2025
Press ReleaseLinkind and Jimmy Darts Partner for Walmart-Exclusive Launch of Matter Smart Bulbs LOS ANGELES, April 15, 2025 /PRNewswire/ — Linkind is proud to announce the… CISION PRNewswireApril 15, 2025
Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program SAN JOSE, Calif., April 15, 2025 /PRNewswire/ — Complete Genomics, a leading innovator… CISION PRNewswireApril 15, 2025
